Peter Fleming
- Endocrinology top 0.2%
- Enterobacteriaceae and Cronobacter Research 3
- Molecular Medicine top 1%
- Antibiotic Resistance in Bacteria 9
- Infectious Diseases top 1%
- Antimicrobial Resistance in Staphylococcus 3
- Food Science top 1%
- Salmonella and Campylobacter epidemiology 8
- Biotechnology top 2%
-
- Bacterial Infections and Vaccines 7
-
- Pneumonia and Respiratory Infections 7
-
- Cystic Fibrosis Research Advances 4
-
- Streptococcal Infections and Treatments 3
- Co-authors
- Mohamed A. KarmaliH. LiorCorazon LimHenry LevisonRonald GoldMary CoreyAlan IslesCharles G. Prober
- Journals
- The Journal of Pediatrics (4 papers)Journal of Clinical Microbiology (4 papers)Antimicrobial Agents and Chemotherapy (3 papers)
- Partner nations
- CanadaUnited KingdomUnited States
In The Last Decade
Peter Fleming
41 papers receiving 2.9k citations
Hit Papers
Peers
Comparison fields: 5 of 119
- Endocrinology 1.3k
- Molecular Medicine 400
- Infectious Diseases 1.2k
- Food Science 705
- Biotechnology 296
Countries citing papers authored by Peter Fleming
This map shows the geographic impact of Peter Fleming's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Fleming with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Fleming more than expected).
Fields of papers citing papers by Peter Fleming
This network shows the impact of papers produced by Peter Fleming. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Fleming. The network helps show where Peter Fleming may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Peter Fleming, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2018 | 2 | |
| 3 | 2011 | 38 | |
| 4 | 2000 | 4 | |
| 5 | 1996 | 68 | |
| 6 | 1990 | 20 | |
| 7 | 1988 | 21 | |
| 8 | Pseudomonas cepacia infection in cystic fibrosis: An emerging problembreakdown → | 1984 | 709 |
| 9 | 1983 | 62 | |
| 10 | 1983 | 61 | |
| 11 | 1982 | 82 | |
| 12 | 1981 | 11 | |
| 13 | 1980 | 43 | |
| 14 | 1979 | 193 | |
| 15 | Ampicillin-Resistant Strains of Hemophilus influenzae type B : Committee on Infectious Diseases | 1975 | 42 |
| 16 | 1974 | 8 | |
| 17 | 1972 | 16 | |
| 18 | 1969 | 14 | |
| 19 | 1963 | 88 | |
| 20 | 1960 | 40 |
About Peter Fleming
Peter Fleming is a scholar working on Molecular Medicine, Microbiology, Endocrinology, Food Science and Infectious Diseases, having authored 42 papers that have together received 3.3k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (9 papers), Salmonella and Campylobacter epidemiology (8 papers), Bacterial Infections and Vaccines (7 papers), Pneumonia and Respiratory Infections (7 papers), Cystic Fibrosis Research Advances (4 papers), Enterobacteriaceae and Cronobacter Research (3 papers), Antimicrobial Resistance in Staphylococcus (3 papers) and Streptococcal Infections and Treatments (3 papers). The work is most often cited by research in Endocrinology (1.3k citations), Molecular Medicine (400 citations), Infectious Diseases (1.2k citations), Food Science (705 citations) and Biotechnology (296 citations). Peter Fleming has collaborated with scholars based in Canada, United Kingdom and United States. Frequent co-authors include Mohamed A. Karmali, H. Lior, Corazon Lim, Henry Levison, Ronald Gold, Mary Corey, Alan Isles, Charles G. Prober, Ian MacLusky and M. Goldner. Their work appears in journals such as The Journal of Pediatrics, Journal of Clinical Microbiology, Antimicrobial Agents and Chemotherapy, The Lancet and Journal of Bacteriology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.